(Q45066174)

English

Vinorelbine and low-dose cyclophosphamide in the treatment of pediatric sarcomas: pilot study for the upcoming European Rhabdomyosarcoma Protocol

scientific article published in October 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Vinorelbine and low-dose cyclophosphamide in the treatment of pediatric sarcomas: pilot study for the upcoming European Rhabdomyosarcoma Protocol (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

rhabdomyosarcoma

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Gian Luca De Salvo

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Cristina Meazza

object named as

Cristina Meazza

6

0 references

Michela Casanova

object named as

Michela Casanova

1

0 references

author name string

Gianni Bisogno

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Johannes H M Merks

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Katia Tettoni

7

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Massimo Provenzi

8

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Ida Mazzarino

9

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Modesto Carli

10

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

language of work or name

0 references

publication date

1 October 2004

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

101

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1664-1671

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Biology and therapy of pediatric rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20544

7 January 2021

based on heuristic

inferred from DOI database lookup

Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20544

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20544

7 January 2021

based on heuristic

inferred from DOI database lookup

Vinorelbine in previously treated advanced childhood sarcomas: evidence of activity in rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20544

7 January 2021

based on heuristic

inferred from DOI database lookup

High-time chemotherapy or high time for low dose

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20544

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20544

7 January 2021

based on heuristic

inferred from DOI database lookup

The Intergroup Rhabdomyosarcoma Study-I. A final report

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20544

7 January 2021

based on heuristic

inferred from DOI database lookup

The Intergroup Rhabdomyosarcoma Study-II.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20544

7 January 2021

based on heuristic

inferred from DOI database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20544

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral etoposide for refractory and relapsed neuroblastoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20544

7 January 2021

based on heuristic

inferred from DOI database lookup

Vinca alkaloids: anti-vascular effects in a murine tumour

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20544

7 January 2021

based on heuristic

inferred from DOI database lookup

Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: results of a phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20544

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of leukemia after chemotherapy and radiation treatment for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20544

7 January 2021

based on heuristic

inferred from DOI database lookup

Second malignant neoplasms in children treated for rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20544

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.20544

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45066174&oldid=2064401791"